Clouds. 54.1   F New York
AI-Powered News Summarizer
Top Stories

New York City public schools will close tomorrow as coronavirus cases rise

November 18, 2020. Summarized by summa-bot.

New York City Mayor Bill de Blasio announced Wednesday that schools will be closed tomorrow.

Watch the moment:

The United States plans to have about 40 million doses of Covid-19 vaccine available to distribute by the end of the year, Health and Human Services Secretary Alex Azar said during a briefing on Wednesday.

The companies Pfizer and Moderna this week both announced that their vaccine candidates were about 95% effective in Phase 3 trials.

Millions of children have missed routine vaccinations during the Covid-19 pandemic, and that is putting the US at risk from diseases like measles, whooping cough and polio, according to new data from Blue Cross Blue Shield Association released Wednesday.

“The new BCBSA vaccine data, based on medical claims from millions of Blue Cross and Blue Shield (BCBS) members, provides clear evidence that the United States is at risk of widespread outbreaks of preventable disease,” the group said in a statement.

The German biotech company BioNTech is working on a formula for its vaccine that would allow it to be shipped at room temperature, CEO Uğur Şahin told CNN’s Frederik Pleitgen in an exclusive interview on Wednesday.

Concerns were raised that it would be difficult to distribute the vaccine BioNTech is working on with US pharmaceutical giant Pfizer because it needs to be stored at about minus 75 degrees Celsius, which is about 50 degrees colder than any vaccine currently used in the United States.

German pharmaceutical company BioNTech, which has been working on a Covid-19 vaccine with US Pharmaceutical giant Pfizer, will file paperwork for the emergency use of its vaccine in the United States on Friday, the company CEO, Uğur Şahin told CNN in an interview on Wednesday.

Earlier today, Pfizer announced that a final analysis of the Phase 3 trial of its coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns.

Pfizer announced its Covid-19 vaccine was 95% effective in preventing infection, according to a final analysis of its Phase 3 trial.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.